As a direct result of APMA and its coalition partners' advocacy efforts, House Energy & Commerce Chair Rep. Brett Guthrie (R-KY) and Rep. Brittany Pettersen (D-CO) introduced the bipartisan HR 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025, which includes a technical fix to the MATE Act. APMA continues to keep the pressure on Congress and urged the Committee to maintain this critical provision during today’s hearing to markup of this bill.
HR 2483 reauthorizes a crucial program aimed at improving treatment and recovery services for substance use disorders. Section 402 of the bill includes a technical fix to address gaps that were unintentionally created by the passage of the MATE Act in 2023. The MATE Act was designed to establish training requirements for providers who prescribe narcotics, particularly opioids, and when the legislation was originally drafted, certain organizations and certifying bodies, like APMA and CPME, were inadvertently excluded. It also addresses the exclusion of recent podiatric physician graduates from being similarly exempted like their osteopathic and allopathic colleagues.
To read this letter and all other comment letters, visit www.apma.org/CommentLetters. Email the APMA Advocacy team with any questions or comments at Advocacy@apma.org. Members can find DEA MATE compliance resources at www.apma.org/DEAMATE.